# Quality Score Report: ADR-002 Quality Framework Selection (Iteration 3)

## L0 Executive Summary

**Score:** 0.9195/1.00 | **Verdict:** REVISE | **Weakest Dimension:** Internal Consistency (0.90)

**One-line assessment:** The iteration 3 Evidence Code Legend fix is effective and genuine — all 18 cited evidence codes are now defined within the document, raising Evidence Quality (0.85 -> 0.91) and Traceability (0.88 -> 0.92) — but the Phase Summary cumulative REQ count discrepancy (states "14 REQs", correct count is ~16) identified in iteration 2 was not fixed, holding Internal Consistency at 0.90 and keeping the composite at 0.9195, just below the 0.92 threshold.

---

## Scoring Context

- **Deliverable:** `projects/PROJ-017-llm-skill-testing/decisions/ADR-002-quality-framework-selection.md`
- **Deliverable Type:** ADR (Architecture Decision Record)
- **Criticality Level:** C3 (per AE-003: new or modified ADR, auto-C3 minimum)
- **Scoring Strategy:** S-014 (LLM-as-Judge)
- **SSOT Reference:** `.context/rules/quality-enforcement.md`
- **Scored:** 2026-03-04
- **Iteration:** 3 (prior scores: iteration 1 = 0.911 REVISE; iteration 2 = 0.907 REVISE)
- **Revision Applied for Iteration 3:** Added Evidence Code Legend table in References section defining 14 E-NNN codes (E-002, E-003, E-004, E-006, E-008 through E-011, E-013 through E-017, E-023) and 4 CONV-NNN codes (CONV-001, CONV-002, CONV-003, CONV-006) with Type, Source Location, and Summary columns.
- **Anti-Leniency Calibration:** Pipeline ADV scores average 0.04-0.055 below self-assessed scores. Strict rubric applied. Uncertain scores resolved downward.

---

## Score Summary

| Metric | Value |
|--------|-------|
| **Weighted Composite** | 0.9195 |
| **Threshold** | 0.92 (H-13) |
| **Verdict** | REVISE |
| **Strategy Findings Incorporated** | No |
| **Prior Iteration Score** | 0.907 REVISE (iteration 2) |
| **Delta from Prior** | +0.0125 (Evidence Quality 0.85 -> 0.91; Traceability 0.88 -> 0.92; Internal Consistency, Methodological Rigor, Completeness, Actionability unchanged) |

**Iteration 3 fix assessment:** The Evidence Code Legend fix directly resolves the primary blocker cited in iterations 1 and 2. All 18 cited evidence codes (E-002 through E-023 used in argument, CONV-001, -002, -003, -006) are now defined within the document with Source Location and Summary columns sufficient for claim-level orientation. The fix is genuine and appropriate — not cosmetic. It raises the composite by +0.0125.

**Remaining blocker:** The Phase Summary table "Cumulative Coverage" for Phase 2 row still states "14 REQs." The correct count is 16 unique REQs cumulative through Phase 2 (Phase 1: 5 unique REQs; Phase 2 adds 11 new REQs, since REQ-003 appears in both rows). This was Priority 2 in the iteration 2 recommendation list and was not addressed. It holds Internal Consistency at 0.90, preventing the composite from clearing 0.92.

---

## Dimension Scores

| Dimension | Weight | Score | Weighted | Evidence Summary |
|-----------|--------|-------|----------|-----------------|
| Completeness | 0.20 | 0.92 | 0.1840 | All ADR sections present with depth; 3 steelmans, 21 REQs, 8 risks, 4-phase roadmap, 7 assumptions, 6 decision review triggers; REQ-011/-018 PARTIAL correctly acknowledged |
| Internal Consistency | 0.20 | 0.90 | 0.1800 | Arithmetic fixes verified (2.900, delta -0.785); self-review composite correct; risk portfolio consistent; Phase Summary "14 REQs" is arithmetically incorrect (correct: ~16 unique through Phase 2) — unfixed from iteration 2 |
| Methodological Rigor | 0.20 | 0.93 | 0.1860 | Nygard ADR; S-003 steelman all 3 options; Kepner-Tregoe 7-dimension weighted scoring; 14-test sensitivity zero flips; S-002/S-004/S-007 applied; weight derivation rationale not included (inherited by reference) |
| Evidence Quality | 0.15 | 0.91 | 0.1365 | Evidence Code Legend now defines all 18 cited codes with Type, Source Location, Summary — resolves primary gap; N=30 SINGLE-SOURCE flagged; 0.55 confidence disclosed; Source Location entries remain abbreviated (e.g., "Phase 4, L2.1") |
| Actionability | 0.15 | 0.94 | 0.1410 | CLI commands specified; 4-phase roadmap with gates, costs, week timelines; 3 conditional Phase 0 branches; 7 assumptions with resolution paths and deadlines; 6 decision review triggers with conditions and actions |
| Traceability | 0.10 | 0.92 | 0.0920 | Evidence Code Legend resolves E-NNN and CONV-NNN traceability gap; 21 REQs individually traced; 8 risks to Phase 3B; 6 artifacts with repo-relative paths; "23 evidence items cited" claim unverifiable (minor) |
| **TOTAL** | **1.00** | | **0.9195** | |

---

## Detailed Dimension Analysis

### Completeness (0.92/1.00)

**Evidence:**

All required Nygard ADR sections are present with substantive content:
- Navigation table (H-23 compliant) with 13 anchored sections
- L0/L1/L2 three-level structure implemented throughout
- Three options with: steelman (S-003, H-16 compliant), 7-dimension Kepner-Tregoe scoring table, "Why Not Selected" rationale
- Composite scoring summary with sensitivity analysis note
- Consequences section: 5 positive, 5 negative, 3 neutral
- Risk register: 8 risks in L×C matrix with residual and option-specificity flags
- Implementation roadmap: 4 phases with objectives, components, integration targets, specific REQ satisfaction, quality attributes, and gate criteria
- Requirements traceability: 21 REQs individually mapped to component and phase; 8 MUST-HAVE acceptance criteria satisfied
- Open items: 7 assumptions with risk level, impact-if-wrong, resolution path, deadline
- Strategic implications: 3-stage evolution path, 3 systemic consequences, 6 decision review triggers
- Self-review: S-010 constitutional compliance (7 principles), S-014 self-score with arithmetic, S-002 devil's advocate, S-004 pre-mortem
- Count escalation explanation present and clear: "Phase 3A V&V reported 12/21 PASS with 9 PARTIAL. This ADR advances 7 items from PARTIAL to PASS because the architectural decisions made here... directly satisfy requirements that Phase 3A correctly classified as PARTIAL."
- Evidence Code Legend added in iteration 3: defines 14 E-NNN codes and 4 CONV-NNN codes

**Gaps:**

- REQ-011 and REQ-018 remain PARTIAL with "implementation detail deferred" — these are genuine architectural completeness gaps, correctly acknowledged with clear resolution paths; they are honest scope items rather than missing content
- T3 tier (hybrid-proxy) is architecturally reserved but undesigned — acknowledged as neutral consequence

**Improvement Path:**

Neither gap prevents PASS at this dimension level. REQ-011 and REQ-018 are appropriately scoped to implementation; an ADR-level resolution is not required. Score reflects full coverage of the ADR's scope as declared.

---

### Internal Consistency (0.90/1.00)

**Evidence:**

Primary fixes verified consistent across all instances:
- Option A weighted total: 2.900 in scoring matrix (with inline verification comment showing full calculation), Composite Scoring Summary, and delta. All four instances match.
- Count escalation: Decision Rationale Summary correctly cites Phase 3A historical counts ("12/21 formal requirements PASS; 9/21 PARTIAL") while Requirements Traceability section shows the updated ADR counts (19/21 PASS) with explicit explanation of the escalation. No contradiction.
- Self-review S-014 composite: (0.95×0.20)+(0.94×0.20)+(0.93×0.20)+(0.92×0.15)+(0.94×0.15)+(0.95×0.10) = 0.190+0.188+0.186+0.138+0.141+0.095 = 0.938. Verified correct.
- Risk portfolio: 8 pre-mitigation, 5 mitigated to GREEN, 3 remaining YELLOW. Individual RISK-IDs in the register match the portfolio summary. Consistent.
- Three-option score ranking (B: 3.685, C: 3.155, A: 2.900) is consistent between the scoring tables and the Composite Scoring Summary.

**Gaps:**

Phase Summary table cumulative REQ count discrepancy persists from iteration 2:
- Phase 1 row: "REQ-003, -009, -010, -011, -017" = 5 unique REQs
- Phase 2 row: "REQ-001 through -008, -012 through -015" = REQ-001 to REQ-008 (8 REQs) plus REQ-012 to REQ-015 (4 REQs) = 12 items, of which REQ-003 is a repeat of Phase 1
- Unique REQs cumulative through Phase 2: 5 (Phase 1) + 11 (Phase 2 net of repeat) = 16
- Phase Summary states: "T1 + T2 statistical (14 REQs)"
- The figure "14" does not reconcile with any defensible count: not the Phase 2 row total (12), not the Phase 1+2 unique count (16), not the Phase 1+2 sum without dedup (17)
- This is an arithmetic inconsistency in a secondary table, not a decision-logic error, but it is a factual inconsistency that persisted through three iterations without correction

**Improvement Path:**

Single targeted fix: update Phase Summary "Cumulative Coverage" for Phase 2 row from "14 REQs" to "16 REQs" (or reconcile by removing REQ-003 from the Phase 2 "Requirements Satisfied" list to avoid the double-count and update cumulative to reflect the correct unique count). This is a one-line correction.

---

### Methodological Rigor (0.93/1.00)

**Evidence:**

- Nygard ADR format applied correctly: Status, Context, Decision, Consequences, Risks, Implementation, Strategic Implications
- S-003 Steelman: all 3 options receive steelman before evaluation; each includes "Where this steelman is strongest:" condition qualifier that identifies the specific scenario where each option would be the correct choice — unusually rigorous
- Kepner-Tregoe weighted decision analysis: 7 dimensions with explicit weights summing to 1.00 and 5-point scoring scale; all three options scored on all 7 dimensions
- Sensitivity analysis: 14 single-dimension weight perturbations with zero-flip result; threshold identified — requires simultaneously eliminating time-to-first-value weight AND tripling competitive defensibility weight to flip; "this weight configuration is inconsistent with Phase 1D requirements" provides specific external constraint grounding the conclusion
- S-002 Devil's Advocate: specific challenge ("time-to-value advantage is illusory") with specific mechanism-level rebuttal distinguishing "time to first result" from "time to full framework completion"
- S-004 Pre-Mortem: specific failure scenario (RISK-002 + RISK-005 combined), specific mitigations mapped to design elements, explicit "Does this change the recommendation? No" conclusion with rationale
- S-007 Constitutional compliance: 7 principles individually assessed with compliance evidence
- ASM-007 tests robustness of Option A adoption friction score: "Even with improved score (2/5), Option A total rises to ~2.895 -- still well below Option B" — methodological self-checking
- L×C risk scoring with numeric scores, residual classification, and option-specificity flags

**Gaps:**

- Trade study dimension weight derivation (e.g., why Time to First Value = 0.25, highest weight) is not explained in this ADR; inherited from Phase 5 by reference. A reader cannot evaluate whether the weights are appropriate without navigating to the trade study.
- 14 individual sensitivity test results are not tabulated in this ADR; only the summary conclusion (zero flips) is present. Inherited from Phase 5 by reference.

Both are minor gaps given that the methodology is fully documented in a cited source; these are scope decisions for an ADR that is synthesizing from a longer trade study rather than performing the analysis from scratch.

**Improvement Path:**

Add a brief weight derivation paragraph (one to three sentences: "Time to First Value receives the highest weight (0.25) because Phase 1D evaluation criteria identified the 6-12 month competitive window as a primary constraint; delivery inside the window is existential"). This would raise to 0.95+ on this dimension.

---

### Evidence Quality (0.91/1.00)

**Evidence:**

The iteration 3 fix is effective:
- Evidence Code Legend defines all 14 E-NNN codes cited in argument: E-002, E-003, E-004, E-006, E-008, E-009, E-010, E-011, E-013, E-014, E-015, E-016, E-017, E-023
- Evidence Code Legend defines all 4 CONV-NNN codes cited in argument: CONV-001, CONV-002, CONV-003, CONV-006
- Each legend entry includes: Code, Type, Source Location, and Summary column — a reader can now understand what each evidence code claims and where to locate it
- Cross-verification: all E-codes cited in options scoring tables appear in the legend; all CONV codes cited in the Forces table appear in the legend. No orphaned codes.
- Pre-existing evidence strengths maintained: N=30 SINGLE-SOURCE explicitly flagged with arxiv ID (2511.19794); competitive window confidence stated as "0.55 confidence"; cost estimates with explicit "+/-30%" uncertainty range; promptfoo specifics verifiable (10.8k GitHub stars, MIT license); arithmetic correction with inline verification comment

**Gaps:**

- Source Location entries in the Evidence Code Legend remain abbreviated: "Phase 4, L2.1" or "Phase 1B, Section L1.5" — a reader still must navigate to the referenced file to locate the specific evidence. The legend clarifies what the code means and where to look, but does not eliminate the need for external navigation entirely. This is a level-of-detail issue that prevents "all claims with credible citations" from being fully self-contained, but it is substantially better than undefined codes.
- The "23 evidence items cited" claim in the self-review constitutional compliance check (P-011 line) is not enumerated, making it unverifiable. A count of the legend entries plus inline phase references shows approximately 18 legend codes plus additional inline phase references — the "23" claim cannot be independently confirmed from the document.

**Improvement Path:**

The abbreviated Source Location issue is the remaining constraint. Expanding two or three of the highest-stakes evidence entries (e.g., E-002, E-006) to include a specific section reference would move this to 0.93. The "23 items" claim could be replaced with the exact count or an enumeration.

---

### Actionability (0.94/1.00)

**Evidence:**

This dimension remains the strongest. The implementation roadmap provides specific, implementable guidance:
- Phase 0: "4 engineer-hours," specific success criterion naming one agent (ps-researcher), three conditional gate branches with specific actions per gap type (capability gap → Phase 1; configuration gap → narrowed scope; discoverability gap → reduced scope)
- Phase 1: Exact CLI command (`jerry skill-test smoke <skill-path>`), binary exit code integration with GitHub Actions as explicit target, specific quality attribute IDs with numeric thresholds (QA-001: 100% determinism, QA-003: <=60s, QA-004: $0.00, QA-008: <=2% FPR)
- Phase 2: Exact CLI command (`jerry skill-test standard <skill-path>`), cost estimate displayed before execution, specific REQ satisfaction list
- Phase 3: Exact CLI command, N-calibration study as parallel activity with specific N values to test (N=10, 20, 30, 50), scheduled CI frequency tied to criticality (C3+ work)
- 7 assumptions: each with Risk Level, Impact If Wrong, Resolution Path, and Deadline
- 6 decision review triggers: each with specific Condition and specific Action per trigger

**Gaps:**

- Phases 1-3 lack engineer-hours effort estimates; only Phase 0 has "4 engineer-hours." Phases 1-3 provide week-range timelines but not effort point estimates.
- The N-calibration study lacks ownership assignment or specific methodology specification.

These are minor omissions relative to the level of specificity elsewhere.

**Improvement Path:**

Add rough effort estimates for Phases 1-3 (e.g., "~8-10 engineer-days" for Phase 1). This is optional at the PASS threshold level — it would not change the composite outcome meaningfully.

---

### Traceability (0.92/1.00)

**Evidence:**

The iteration 3 fix substantially resolves the traceability gap:
- Evidence Code Legend now makes the claim-to-evidence chain navigable: a reader can follow "Option A, Time to first value, Score=1, [ADR-001, E-003]" through the legend ("E-003: Timeline | ADR-001 Option A evaluation | Option A: 3-6 months minimum, 7 components from scratch") to the specific source document section
- 21 REQs individually mapped to Component and Phase columns
- 8 risks individually traced to Phase 3B register IDs (RISK-002 through RISK-015)
- 7 assumptions traced with ASM-IDs (ASM-001 through ASM-007), each with resolution path
- 6 input artifacts listed with repo-relative file paths
- Forces section maps each force to CONV-ID and prior artifact
- Arithmetic correction has explicit provenance: "Corrected per ADV-5 finding"
- Count escalation explanation specifically traces to "Phase 3A V&V" with the count transition documented
- Constitutional compliance check traces each principle to a compliance statement

**Gaps:**

- The "23 evidence items cited" claim in the self-review P-011 compliance check cannot be verified from the document alone. A reader cannot enumerate 23 items independently; the legend shows 18 defined codes plus several additional inline phase references that may bring the total to 23, but the count is not enumerable from the ADR itself.
- Source Location entries in the Evidence Code Legend require external file navigation to reach specific evidence (e.g., "Phase 4, L2.1" requires opening Phase 4 cross-pollination synthesis and finding section L2.1). The chain is navigable but not self-contained.

**Improvement Path:**

The unverifiable "23 evidence items" claim is the simplest fix: replace with the exact count from the legend (18 defined codes) or expand to include all inline phase references in the enumeration. The Source Location abbreviation is acceptable at 0.9+ level — the chain exists and is navigable.

---

## Improvement Recommendations (Priority Ordered)

| Priority | Dimension | Current | Target | Recommendation |
|----------|-----------|---------|--------|----------------|
| 1 | Internal Consistency | 0.90 | 0.93 | Fix Phase Summary table "Cumulative Coverage" for Phase 2 row: change "T1 + T2 statistical (14 REQs)" to "T1 + T2 statistical (16 REQs)". Derivation: Phase 1 unique (5: REQ-003, -009, -010, -011, -017) plus Phase 2 net-new (11: REQ-001, -002, -004, -005, -006, -007, -008, -012, -013, -014, -015 — excluding REQ-003 already counted in Phase 1) = 16. This single-line fix resolves the only remaining blocker and would raise the composite to approximately 0.9235 (PASS). |
| 2 | Methodological Rigor | 0.93 | 0.95 | Add a one-paragraph weight derivation rationale for the 7 trade study dimensions explaining why Time to First Value receives the highest weight (0.25) — e.g., "time-to-value receives the highest weight because the 6-12 month competitive window identified in Phase 1D makes delivery inside the window an existential constraint, not merely a preference." |
| 3 | Evidence Quality | 0.91 | 0.93 | Expand two or three key Evidence Code Legend entries (e.g., E-002, E-006) to include a full section reference rather than abbreviated location (e.g., "ADR-001, Section: Implementation Phases table, row 'Phase 0'" rather than "ADR-001 Implementation Phases table"). Also update "23 evidence items cited" in constitutional compliance to enumerate or correct the count. |

---

## Iteration Trajectory

| Iteration | Composite | Verdict | Primary Gap |
|-----------|-----------|---------|-------------|
| 1 | 0.911 | REVISE | Arithmetic error (2.795 -> 2.900); count escalation unexplained |
| 2 | 0.907 | REVISE | E-NNN codes undefined; Phase Summary REQ count inconsistency |
| 3 (this) | 0.9195 | REVISE | Phase Summary REQ count inconsistency (14 vs 16); E-NNN gap resolved |

**Trajectory assessment:** The document has improved in each iteration on the dimension targeted by the fix. The remaining blocker is the single unaddressed Priority 2 item from the iteration 2 recommendation list. A one-line correction to the Phase Summary table is sufficient to reach 0.9235 (PASS).

---

## Leniency Bias Check

- [x] Each dimension scored independently before computing composite
- [x] Evidence documented for each score with specific line references and quotes
- [x] Uncertain scores resolved downward (Evidence Quality: 0.91 not 0.92 because Source Location entries remain abbreviated; Internal Consistency: 0.90 not 0.92 because Phase Summary "14 REQs" is arithmetically incorrect and unfixed)
- [x] Iteration 3 calibration applied: this is a revised ADR at iteration 3; scores of 0.90-0.93 are appropriate; scores above 0.93 require documented exceptional evidence
- [x] No dimension scored above 0.94 (Actionability at 0.94 is well-justified by CLI command specificity, conditional gates, and quantitative thresholds)
- [x] Composite arithmetic independently verified: 0.1840 + 0.1800 + 0.1860 + 0.1365 + 0.1410 + 0.0920 = 0.9195
- [x] Anti-leniency calibration: pipeline ADV scores average 0.04-0.055 below self-assessed scores; self-assessed score was 0.938; this score is 0.9195 (delta -0.0185), within the expected range

---

## Session Context Handoff

```yaml
verdict: REVISE
composite_score: 0.9195
threshold: 0.92
weakest_dimension: Internal Consistency
weakest_score: 0.90
critical_findings_count: 0
iteration: 3
improvement_recommendations:
  - "Fix Phase Summary table cumulative REQ count: change '14 REQs' to '16 REQs' for Phase 2 row (unique REQs: Phase 1 = 5, Phase 2 net-new = 11, cumulative = 16). This is the sole remaining PASS blocker."
  - "Add trade study weight derivation rationale paragraph (raises Methodological Rigor 0.93 -> 0.95, optional for PASS)"
  - "Expand Evidence Code Legend Source Location entries for key codes; correct '23 evidence items' count claim (raises Evidence Quality 0.91 -> 0.93, optional for PASS)"
delta_from_prior_adv_score: +0.0125
note: "Iteration 3 fix (Evidence Code Legend) is effective and genuine — all 18 cited codes now defined with Type, Source Location, Summary. This resolves the primary blocker from iterations 1-2 (Evidence Quality 0.85 -> 0.91, Traceability 0.88 -> 0.92). Single remaining blocker: Phase Summary '14 REQs' arithmetic inconsistency (correct: 16) was not fixed in iteration 3. One-line correction yields estimated composite 0.9235 (PASS)."
```
